Initiative, study design (first author and date published) | Result reported | Baseline (or basic service level) [n]a | Final visit or comparison group [n]a | Difference | 95% Confidence interval or P value |
---|---|---|---|---|---|
CCT, pre – post cohort | HbA1c mean mmol/L% (CI) | 9.0 (8.6, 9.4) [n = 137] | 8.8 (8.3, 9.2) [n = 146] | −0.2 | 0.23 for trend |
(Bailie et al. 2004) [20] | |||||
Improved care coordination, cohort follow-up | HbA1c mean mmol/L% (CI) | 9.3 (8.8, 9.8) [n = 295] | 8.9 (8.6, 9.3) [n = 252] | −0.4 | −0.7, –0.1 |
(Bailie et al. 2007) [21] | |||||
IDERP – IHS, cross sectional | HbA1c mmol/L% (% patients <7.0) | not reported | not reported | OR = 1.1 | 0.8, 1.7 |
(Roubideaux 2008)b [23] | |||||
IHS, repeated cross section | HbA1c mean mmol/L% (SE) | 8.9 (0.04) [n = 7110] | 7.9 (0.03) [n = 15537] | −1.0 | 0.0001 (1995 vs 2001) |
(Wilson et al. 2005) [22] | |||||
Care Plus, open prospective cohort | HbA1c mean mmol/L% (CI)c | 8.1 (8.0, 8.2) [n = 354] | 7.2 (6.7, 7.5) [n = 3] | −0.9 | <0.05 (based on CIs) |
(Kenealy et al. 2010) [26] | |||||
Get Checked, pre – post cohort | HbA1c mean mmol/L% (SD) | 8.0 (1.6) [n = 298] | 8.0 (1.6) [n = 298] | 0 | Not reportedd |
(Smith et al. 2011) [27] | |||||
Integrated diabetes service, pre – post cohort | HbA1c mean mmol/L% (SD) | 10.4 (2.2) [n = 30] | 7.9 (1.9) [n = 30] | −2.5 | <0.001 |
(Simmons et al. 2003) [28] | |||||
Foot program – IHS, pre – post incidence study (Schraer et al. 2003) [25] | Amputation incidence (per 1000 person years) | 16.4 (1342 person years) | 6.8 (1628 person years) | −59% | 0.021 |
Special diabetes program, repeated cross section | HbA1c mean mmol/L% | 8.4 [n = 1394] | 7.4 [n = 1839] | −1 | <0.001 |
(Ramesh et al. 2008) [24] | |||||
SLICK, pre – post cohort | HbA1c Mean mmol/L% | 8.12 [n = 285] | 8.01 [n = 285] | −0.11 | 0.176 |
(Virani et al. 2006) [32] | |||||
Evidence based management of diabetes, cluster randomised trial | HbA1c mmol/L% (% <7) | not reported [n = 555] | IG = 22 CG = 20 [n = 678] | RR: 1.26e | 0.219 |
(McDermott et al. 2001) [29] | Persons hospitalised for diabetes reasons (%) | IG = 20 CG = 22 [n = 555] | IG = 12 CG = 20 [n = 678] | IG = –8% CG = –2% | IG = 0.012 CG = 0.514f |
Diabetes hospital episodes (%) | IG =23 CG =30 [n = 555] | IG =19 CG =29 [n = 678] | IG = –4% CG = –1% | IG = 0.015 CG = 0.746f | |
Hypertension management, randomised unblinded control trial | HbA1c mean mmol/L% (SD) | IG = 7.9 (1.9)g CG = 7.7 (1.8) [n = 99] | IG 7.8 (2.1) CG 7.7 (1.9) [n = 95] | IG = –0.1 (1.7) CG = –0.0 (1.3) | >0.05h |
(Tobe et al. 2006) [30] | |||||
DOVE, pre – post cohort | HbA1c mean mmol/L% (CI) | 7.4 (7.0–7.8) [n = 94] | 7.7 (7.4–7.9) [n = not reported] | +0.3 | >0.05 (based on CIs) |
(Ralph-Campbell et al. 2006) [31] |